Skip to main content
SpringerLink
Log in

Zur Diagnostik und Therapie bei schizophrenen Psychosen des Kindes- und Jugendalters

  • Conference paper
Clozapin

  • 27 Accesses

Zusammenfassung

Psychosen sind im Kindesalter selten auftretende Erkrankungen, die einer sehr genauen differentialdiagnostischen Abklärung bedürfen. Ungefähr 0,5 bis 1% aller schizophrenen Psychosen beginnen vor dem 10. und etwa 4% vor dem 15. Lebensjahr. Im Jugendalter und der Adoleszenz kommt es dann zu einem bemerkenswerten Häufigkeitsanstieg, wobei sich ca. 22% aller Ersterkrankungen mit einer Schizophrenie zwischen dem 15. und 19. Lebensjahr manifestieren (Remschmidt 1993).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ackenheil M (1989) Clozapine–pharmacokinetic investigations and biochemical effects in man. Psychopharmacol 99: 32–37

    Article  Google Scholar 

  • American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders DSM-III-R, 3rdn edn rev. Washington: APA, 1987

    Google Scholar 

  • Andreasen NC ( 1984 a) The Scale for the Assessment of Positive Symptoms (SAPS). University of Iowa, Iowa City

    Google Scholar 

  • Andreasen NC (1984b) The Scale for the Assessment of Negative Symptoms (SANS). University of Iowa, Iowa City

    Google Scholar 

  • Bondesson U, Lindström LH (1988) Determination of clozapine and its N-demethylated metabolite in plasma by use of gas chromatography-mass spectrometry with single ion detection. Psychopharmacol 95: 472–475

    CAS  Google Scholar 

  • Brickenkamp R (1975) Test d2. Aufmerksamkeits-Belastungs-Test, %. Aufl. Hogrefe, Göttingen

    Google Scholar 

  • Campbell M, Grega DM, Green WH (1983) Neuroleptic-induced dyskinesias in children. Clin Neuropharmacol 6: 207–222

    Article  PubMed  CAS  Google Scholar 

  • Centorrino F, Baldessarini RJ, Kando JC et al. (1994) Clozapine and metabolites–concentrations in serum and clinical findings during treatment of chronically psychotic patients. J Clin Psychopharmacol 14: 119–125

    Article  PubMed  CAS  Google Scholar 

  • Chung MC, Lin SK, Chang WH (1993) Determination of clozapine and desmethylclozapine in human plasma by high-performance liquid chromatography with ultraviolet detection. J Chromatogr 613: 168–173

    Article  PubMed  CAS  Google Scholar 

  • Elliger T, Englert E, Freisleder FJ et al. (1994) Zur Behandlung schizophrener Psychosen des Kindes-und Jugendalters mit Clozapin (Leponex). Konsensuskonferenz vom 4. März 1994. Kinder-und Jugendpsychiatrie. Z Kinder Jugendpsychiatr 22: 1–2

    Google Scholar 

  • Gillberg IC, Hellgren L, Gillberg C (1993) Psychotic disorders diagnosed in adolescence. Outcome at age 30 years. J Child Psychol Psychiatr 34: 1171–1185

    Google Scholar 

  • Gold R, Sponheim B, Sohr R (1990) Serumkonzentration von Clozapin bei Alemoxan Therapie. Z Klin Med 45: 2039–2042

    Google Scholar 

  • Green WH, Padron-Gayol M, Hardesty AS (1992) Schizophrenia with childhood onset: a phenomenological study of 38 cases. J Am Acad Child Adolesc Psychiatry 31: 968–976

    Article  PubMed  CAS  Google Scholar 

  • Gualtieri CT, Quade D, Hicks RE (1984) Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents. Am J Psychiatry 141: 20–23

    PubMed  CAS  Google Scholar 

  • Gualtieri CT, Schroeder SR, Hicks RE(1986) Tardive dyskinesia in young mentally retarded individuals. Arch Gen Psychiatry 43: 335–340

    Article  PubMed  CAS  Google Scholar 

  • Guy W (1976) ECDEU Assessment Manual for Psychopharmacology, rev. Rockville (MD): National Institute of Mental Health, 1976 DHEW Pub No (ADM) 76–338

    Google Scholar 

  • Haring C (1988) Clozapine plasma levels determined by high-performance liquid chromatography with ultraviolett detection. J Chromatogr 428: 160–166

    Article  PubMed  CAS  Google Scholar 

  • Haring C, Meise U, Humpel C, Saria A, Fleischhacker WW, Hinterhuber H (1989) Dose-related plasma levels of clozapine: influence of smoking behaviour, sex and age. Psychopharmacol 99: 38–40

    Article  Google Scholar 

  • Kolvin I, Ounsted C, Humphrey M, McNay A (1971) Studies in the childhood psycho-ses. II. The phenomenology of childhood psychoses. Br J Psychiatry 118: 385–395

    Article  PubMed  CAS  Google Scholar 

  • Krausz M (1990) Schizophrenie bei Jugendlichen–Eine Verlaufsuntersuchung. Psych-iatr Prax 17: 107–114

    CAS  Google Scholar 

  • Lovdahl MJ, Perry PJ, Miller DD (1991) The assay of clozapine and N-desmethylclozapine in human plasma by high-performance liquid chromatography. Ther Drug Monit 13: 69–72

    Article  PubMed  CAS  Google Scholar 

  • Martin M., Remschmidt, H (1983) Ein Nachsorge-und Rehabilitationsprojekt für jugendliche Schizophrene. Z Kinder Jugendpsychiatr 11: 234–242

    Google Scholar 

  • Martin M, Remschmidt H (1984) Rehabilitationsbehandlung jugendlicher Schizophrener. In: Remschmidt H (Hrsg) Psychotherapie mit Kindern, Jugendlichen und Familien, Bd. II. Enke, Stuttgart, S 228–235

    Google Scholar 

  • Martin M (1991) Verlauf der Schizophrenie unter Rehabilitationsbedingungen. Enke, Stuttgart

    Google Scholar 

  • McClellan J, Werry J (1994) Practice parameters for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatr 33: 616–635

    Article  CAS  Google Scholar 

  • National Institute of Mental Health (NIMH): DOTES - Dosage Record and Treatment Emergent Symptom Scale. NIMH, Rockville, Maryland 1976

    Google Scholar 

  • Perry PJ, Miller DD, Arndt SV, Cadoret RJ (1991) Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients. Am J Psychiatry 148: 231–235

    PubMed  CAS  Google Scholar 

  • Piscitelli SC, Frazier JA, McKenna K et al. (1994) Plasma clozapine and haloperidol concentrations in adolescents with childhood-onset schizophrenia–Association with response. J Clin Psychiatr 55: 94–97

    Google Scholar 

  • Remschmidt H, Martin M, Schulz E, Gutenbrunner C, Fleischhaker C (1991) The concept of positive and negative schizophrenia in child and adolescent psychiatry. In: Marneros A, Andreasen NC, Tsuang MT (eds) Negative versus positive schizophrenia, Springer, Berlin Heidelberg New York Tokyo, pp 219–242

    Chapter  Google Scholar 

  • Remschmidt H, Martin M (1992) Die Therapie der Schizophrenie im Jugendalter. Deutsch Ärztebl 89: 387–396

    Google Scholar 

  • Remschmidt H (1993) Childhood and adolescent schizophrenia. Curr Opin Psychiatry 6: 470–479

    Article  Google Scholar 

  • Remschmidt H, Schulz E, Martin M, Warnke A, Trott G (1994) Childhood onset schizophrenia: History of the concept and recent studies. Schizophr Bull 20 (4): 727–745

    PubMed  CAS  Google Scholar 

  • Remschmidt H, Schulz E, Herpertz-Dahlmann B (1996a) Schizophrenic psychoses with manifestation in childhood and adolescence: a guide to diagnosis and drug choice. CNS Drugs 6: 100–112

    Article  Google Scholar 

  • Remschmidt H, Schulz E, Martin M (1996b) Psychotherapie bei schizophrenen Psychosen des Kindes-und Jugendalters. In: Remschmidt H (Hrsg) Psychotherapie im Kindes-und Jugendalter. Thieme, Stuttgart - in Druck

    Google Scholar 

  • Russell AT, Bott L, Sammons C (1989) The phenomenology of schizophrenia occurring in childhood. J Am Acad Child Adolesc Psychiatry 28 (3): 399–407

    Article  PubMed  CAS  Google Scholar 

  • Siefen G, Remschmidt H (1986) Behandlungsergebnisse mit Clozapin bei schizophrenen Jugendlichen. Z Kinder Jugendpsychiatr 14: 245–257

    PubMed  CAS  Google Scholar 

  • Schmidt MH, Blanz B (1992) Behandlungsverlauf und Katamnese von 122 Psychosen in der Adoleszenz. In: Nissen G (Hrsg) Endogene Psychosyndrome und ihre Therapie im Kindes-und Jugendalter. Psychiatriehistorische, entwicklungspsychiatrische, psychopathologische, katamnestische, humangenetische, prognostische, psychotherapeutische und psychopharmakologische Aspekte. Huber, Bern Göttingen Toronto, S 163–177

    Google Scholar 

  • Schooler NR, Kane JM (1982) Research diagnoses for tardive dyskinesias. Arch Gen Psychiatry 39: 486–487

    Article  PubMed  CAS  Google Scholar 

  • Schulz E, Martin M, Remschmidt H (1994a) Zur Verlaufsdynamik schizophrener Erkrankungen in der Adoleszenz. Z Kinder Jugendpsychiatr 22: 262–274

    CAS  Google Scholar 

  • Schulz E, Remschmidt H, Fleischhaker C ( 1994 b): Der Einfluss von Clozapin auf die biogenen Amine im Rahmen der medikamentösen Behandlung von schizophrenen Psychosen des Jugendalters. Z Kinder Jugendpsychiat 22: 285–298

    CAS  Google Scholar 

  • Schulz E, Fleischhaker C, Remschmidt H (1995) Determination of clozapine and its major metabolites in serum samples of adolescent schizophrenic patients by high performace liquid chromatography. Data from a prospective clinical trial. Pharmacopsychiatr 28 (1): 20–25

    Article  CAS  Google Scholar 

  • Schulz E, Fleischhaker C, Remschmidt H (1996) Correlated changes in symptoms and neurotransmitter indices during maintenance treatment with clozapine or conventional neuroleptics in adolescents and young adults with schizophrenia. J Child Adolesc Psychopharmacol 6 (2): 119–131

    Article  PubMed  CAS  Google Scholar 

  • Toenissen LM, Casey DE, McFarland BM (1985) Tardive dyskinesia in the aged: duration of treatment relationships. Arch Gen Psychiatry 42: 278–283

    Article  Google Scholar 

  • Volpicelli SA, Centorrino F, Puopolo PR et al. (1993) Determination of clozapine, norclozapine, and clozapine-N-oxide in serum by liquid chromatography. Clin Chem 39: 1656–1659

    PubMed  CAS  Google Scholar 

  • Weigmann H, Hiemke C (1992) Determination of clozapine and its major metabolites in human serum using automated solid-phase extraction and subsequent isocratic high-performance liquid chromatography with ultraviolet detection. J Chromatogr 583: 209–216

    Article  PubMed  CAS  Google Scholar 

  • Wetzel H, Szegedi A, Anghelescu I et al. (1995) Interaktion von Clozapin mit anderen Psychopharmaka. Vortrag: Workshop 4. Nürnberger Leponex-Gespräch, Nürnberg 10.-11. November 1995

    Google Scholar 

  • World Health Organization (WHO): Tenth revision of the international classification of diseases (ICD-10). WHO, Geneva (1991); (dtsch.: Dilling H, Mombour W, Schmidt MH: Internationale Klassifikation psychischer Störungen. ICD-10. Weltgesundheitsorganisation. Huber, Bern 1991

    Google Scholar 

Download references

Authors
  1. E. Schulz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Fleischhaker
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Remschmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Psychiatrische und Nervenklinik, Universitätskrankenhaus Eppendorf, Universität Hamburg, Martinistraße 52, D-20246, Hamburg, Germany

    D. Naber  & F.-G. Pajonk  & 

  2. Psychiatrische Universitätsklinik Basel, Wilhelm-Klein-Straße 27, CH-4025, Basel, Schweiz

    F. Müller-Spahn

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Schulz, E., Martin, M., Fleischhaker, C., Remschmidt, H. (1997). Zur Diagnostik und Therapie bei schizophrenen Psychosen des Kindes- und Jugendalters. In: Naber, D., Müller-Spahn, F., Pajonk, FG. (eds) Clozapin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60551-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60551-2_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-61691-7

  • Online ISBN: 978-3-642-60551-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation